|Bid||0.7568 x 1000|
|Ask||0.9000 x 1200|
|Day's range||0.8423 - 0.9200|
|52-week range||0.6000 - 1.6500|
|Beta (5Y monthly)||1.46|
|PE ratio (TTM)||N/A|
|Earnings date||25 Sep 2020 - 29 Sep 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||29 Sep 1989|
|1y target est||2.35|
SunLink Health Systems, Inc. (NYSE: American: SSY) today announced that its share repurchase program terminated pursuant to its terms on June 1, 2020. The program was previously suspended on March 24, 2020, due to uncertainly relating to the COVID-19 pandemic.
SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $46,000 (a loss of $0.01 per fully diluted share) for its third fiscal quarter ended March 31, 2020 compared to a loss of $325,000, (a loss of $0.05 per fully diluted share) for the quarter ended March 31, 2019. Net loss for the quarter ended March 31, 2020 was $158,000 (a loss of $0.02 per fully diluted share) compared to net earnings of $1,042,000 ($0.15 per fully diluted share) for the quarter ended March 31, 2019. Net earnings for the quarter ended March 31, 2019 includes a pre-tax gain of $2,136,000 on the sale of a subsidiary’s nursing home and related property.
SunLink Health Systems, Inc. (NYSE American: SSY) announced today that it is suspending its Share Repurchase Program in light of the COVID-19 pandemic. SunLink’s management believes the suspension, while conservative, is prudent given uncertainty regarding the length and severity of the pandemic and potential uncertainty regarding the impact of the pandemic on the timeliness of reimbursement claims and payments under various Federal and state programs (e.g., Medicare and Medicaid) and from private payors. SunLink has the ability to reinstate repurchases as circumstances warrant subject to compliance with applicable SEC rules. The Company is unable to predict the impact of the continuation of the COVID-19 pandemic on the Company’s financial condition, results of operations, business, or prospects.